References
- Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2011
- Economic costs of diabetes in the U.S. in 2007. Diabetes Care 2008;31:596-615
- Standards of medical care in diabetes – 2011. Diabetes Care 2011;34(Suppl 1):S11-S61
- U.S. Renal Data System, USRDS 2011 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2011
- Centers for Disease Control and Prevention. National Chronic Kidney Disease Fact Sheet: General Information and National estimates on Chronic Kidney Diseases in the United States, 2010. Atlanta, GA: U.S. Department of Health and Human Services, CDC; 2010
- Koro CE, Lee BH, Bowlin SJ. Antidiabetic medication use and prevalence of chronic kidney disease among patients with type 2 diabetes mellitus in the United States. Clin Ther 2009;31:2608-17
- KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis 2007;49(Suppl 2):S12-S154
- Meyers JL, Candrilli SD, Kovacs B. Type 2 diabetes mellitus and renal impairment in a large outpatient electronic medical records database: rates of diagnosis and antihyperglycemic medication dose adjustment. Postgrad Med 2011;123:133-43
- KDOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, classification, and Stratification. Natioal Kidney Foundation; 2002. http://www.kidney.org/professionals/KDOQI/guidelines_ckd/toc.htm
- Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-70
- D'Hoore W, Bouchaert A, Tilquin C. Practical consideration on the use of the Charlson comorbidity index with administrative databases. J Clin Epidemiol 1996;49:1429-33
- Schneeweiss S, Maclure M. Use of comorbidity scores for control of confounding in studies using administrative databases. Int J Epidemiol 2000;29:891-8
- Bureau of Labor Statistics. Consumer Price Index. Available from: http://www.bls.gov/cpi/. Accessed 21 January 2011
- Greene WH. Econometric Analysis, 5th edn. Upper Saddle River, New Jersey: Pearson Education, Inc., 2003
- Efron B, Tibhirani R. An introduction to the bootstrap. New York: Chapman and Hall, 1993
- Snyder RW, Berns JS. Use of insulin and oral hypoglycemic medications in patients with diabetes mellitus and advanced kidney disease. Semin Dial 2004;17:365-70
- Wagner EH, Sandhu N, Newton KM, et al. Effect of improved glycemic control on health costs and utilization. JAMA 2001;285:182-9
- Menzin J, Langley-Hawthorne C, Friedman M, et al. Potential short-term economic benefits of improved glycemic control: a managed care perspective. Diabetes Care 2011;24:51-5